Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel. Read more about Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Read more about International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. Read more about Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Read more about Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Read more about PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans. Read more about Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans.
Current human brain applications and challenges of dynamic hyperpolarized carbon-13 labeled pyruvate MR metabolic imaging. Read more about Current human brain applications and challenges of dynamic hyperpolarized carbon-13 labeled pyruvate MR metabolic imaging.
A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria? Read more about A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Read more about E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET.
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Read more about False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
